phosphatidylcholines has been researched along with ezetimibe, simvastatin drug combination in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (ezetimibe, simvastatin drug combination) | Trials (ezetimibe, simvastatin drug combination) | Recent Studies (post-2010) (ezetimibe, simvastatin drug combination) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 153 | 61 | 96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Alexandri, FL; Fiehn, O; Grapov, D; Haeggström, JZ; Hyötyläinen, T; Newman, JW; Orešič, M; Pedersen, TL; Pernow, J; Settergren, M; Snowden, SG; Wheelock, CE | 1 |
1 trial(s) available for phosphatidylcholines and ezetimibe, simvastatin drug combination
| Article | Year |
|---|---|
High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Azetidines; Ceramides; Cholesterol; Cholesterol, LDL; Discriminant Analysis; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Phosphatidylcholines; Simvastatin; Sphingomyelins; Treatment Outcome; Triglycerides | 2014 |